GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anuh Pharma Ltd (BOM:506260) » Definitions » EV-to-FCF

Anuh Pharma (BOM:506260) EV-to-FCF : (As of Dec. 14, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Anuh Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Anuh Pharma's Enterprise Value is ₹10,586 Mil. Anuh Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil. Therefore, Anuh Pharma's EV-to-FCF for today is .

The historical rank and industry rank for Anuh Pharma's EV-to-FCF or its related term are showing as below:

BOM:506260' s EV-to-FCF Range Over the Past 10 Years
Min: -23.43   Med: 0   Max: 146.29
Current: 135.66

During the past 13 years, the highest EV-to-FCF of Anuh Pharma was 146.29. The lowest was -23.43. And the median was 0.00.

BOM:506260's EV-to-FCF is ranked worse than
86.91% of 550 companies
in the Drug Manufacturers industry
Industry Median: 25.795 vs BOM:506260: 135.66

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Anuh Pharma's stock price is ₹218.85. Anuh Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹11.770. Therefore, Anuh Pharma's PE Ratio (TTM) for today is 18.59.


Anuh Pharma EV-to-FCF Historical Data

The historical data trend for Anuh Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anuh Pharma EV-to-FCF Chart

Anuh Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.26 -18.20 15.03 6.62 148.09

Anuh Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 148.09 - -

Competitive Comparison of Anuh Pharma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Anuh Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anuh Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anuh Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Anuh Pharma's EV-to-FCF falls into.



Anuh Pharma EV-to-FCF Calculation

Anuh Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10585.727/0
=

Anuh Pharma's current Enterprise Value is ₹10,586 Mil.
Anuh Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anuh Pharma  (BOM:506260) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Anuh Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=218.85/11.770
=18.59

Anuh Pharma's share price for today is ₹218.85.
Anuh Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹11.770.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Anuh Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Anuh Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Anuh Pharma Business Description

Traded in Other Exchanges
N/A
Address
Dr. Annie Besant Road, North Wing, 3-A, Shiv Sagar Estate, Worli, Mumbai, MH, IND, 400 018
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.

Anuh Pharma Headlines

No Headlines